Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuplin PRO 22.5 mg special use surveillance in prostate cancer
jRCT1080223158
- Sponsor
- Takeda
- Start
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of Leuplin PRO in prostate cancer (PCa), sponsored by Takeda.
02
Drugs
Leuplin PRO
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT1080223158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223158.